503 — Lansen Pharmaceutical Holdings Share News
0.000.00%
HealthcareHighly SpeculativeSmall Cap
- HK$750.60m
- HK$527.08m
- $65.56m
HK Exchange says 12 firms buy back shares
HK Exchange says seven firms buy back shares
HK Exchange says six firms buy back shares
HK Exchange says 10 firms buy back shares
HK Exchange says five firms buy back shares
Brief: Lansen Pharmaceutical Holdings Group Sees Noticeable Decrease In FY Net Profit
HK Exchange says 29 firms buy back shares
Brief: Lansen Pharmaceutical Holdings Says Unit to Buy Stake in Tianjin Robustnique Biotechnology
HK Exchange says 25 firms buy back shares
Brief: Cathay International Says Lansen Pharma Proposes Disposal Of Shares In Zheijang Starry Pharma
Brief: Cathay International Says Lansen Pharmaceutical's Hou Song To Step Down As CFO
Brief: Lansen Pharmaceutical's Hou Song Resigns As Executive Director
Brief: Lansen Pharmaceutical Holdings Posts HY Profit Attributable $10.6 Mln, Down 52.3 Pct
Brief: Lansen Pharmaceutical Holdings Expects Decrease In HY Net Profit
Brief: Lansen Pharmaceutical Says Unit Sold 2.4 Mln Starry Shares
Brief: Lansen Pharmaceutical Holdings Entered Agreement With Botai To Distribute Collagen Injectable Filler In PRC
Brief: Lansen Pharmaceutical's Unit To Provide A Shareholder Loan To Natural Dailyhealth Holdings
Brief: Lansen Pharmaceutical Holdings Posts FY Profit Attributable Of $15.6 Million
Brief: Lansen Pharmaceutical Holdings Appoints Chen Li As Executive Managing Director & CEO